Breast Cancer

SAN ANTONIO — Use of fertility preservation or assisted reproductive technology did not increase recurrence risk among patients with hormone receptor-positive breast cancer who paused endocrine therapy to become pregnant, results showed.

Researchers in Peru tested the efficacy of an oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids in alleviating menopause symptoms.

Alana L. Welm, PhD, will receive the AACR Outstanding Investigator Award for Breast Cancer Research during this year’s San Antonio Breast Cancer Symposium.

Kornelia Polyak, MD, PhD, FAACR, will receive this year’s AACR Distinguished Lectureship in Breast Cancer Research at San Antonio Breast Cancer Symposium.

Women who regularly attended their mammogram screenings before a breast cancer diagnosis had up to a 72% reduced risk for death compared with those who attended none, according to a recent study.

Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.

Despite both patients and oncologists approving of complementary and integrative therapies as part of cancer management, a survey identified a disconnect between oncologists’ perception of patient interest and actual attitudes.

For individuals diagnosed with cancer, guideline-concordant exercise reduced all-cause mortality by 25% compared with patients with cancer who did not exercise, study results published in Journal of Clinical Oncology showed.

Statin use after breast cancer diagnosis was associated with reduced breast cancer mortality and reduced serum cholesterol levels compared with not using a statin, according to cohort study results published in JAMA Network Open.

To address ongoing chemotherapy drug shortages, ASCO convened a multidisciplinary panel of oncologists, ethicists and patient advocates to expedite clinical guidance for navigating care where rationing or alternative therapies are needed.